Pre-hospital treatment of patients with acute coronary syndrome: Recommendations for medical emergency teams. Expert position update 2022
- PMID: 35514089
- PMCID: PMC9273237
- DOI: 10.5603/CJ.a2022.0026
Pre-hospital treatment of patients with acute coronary syndrome: Recommendations for medical emergency teams. Expert position update 2022
Conflict of interest statement
Figures

Similar articles
-
[Pre-hospital management of acute coronary syndrome].Soins. 2015 Mar;(793):39-43. Soins. 2015. PMID: 26040140 French.
-
Acute coronary syndromes.Dis Mon. 2013 May;59(5):202-9. doi: 10.1016/j.disamonth.2013.03.006. Dis Mon. 2013. PMID: 23642274 Review. No abstract available.
-
Anti-aggregation therapy in patients with acute coronary syndrome - recommendations for medical emergency teams. Experts' standpoint.Kardiol Pol. 2017;75(4):399-408. doi: 10.5603/KP.a2017.0057. Kardiol Pol. 2017. PMID: 28421594 No abstract available.
-
[Acute coronary syndrome in the prehospital phase and in the emergency department].Anaesthesiologie. 2022 Jun;71(6):485-492. doi: 10.1007/s00101-022-01129-4. Anaesthesiologie. 2022. PMID: 35925145 German.
-
Treatment of patients with acute coronary syndrome: Recommendations for medical emergency teams: Focus on antiplatelet therapies. Updated experts' standpoint.Cardiol J. 2018;25(3):291-300. doi: 10.5603/CJ.a2018.0042. Epub 2018 Apr 19. Cardiol J. 2018. PMID: 29671864 Review.
Cited by
-
Cangrelor - Expanding therapeutic options in patients with acute coronary syndrome.Cardiol J. 2024;31(1):133-146. doi: 10.5603/cj.96076. Epub 2023 Nov 15. Cardiol J. 2024. PMID: 37964649 Free PMC article.
-
External validation of the Manchester Acute Coronary Syndromes ECG risk model within a pre-hospital setting.Emerg Med J. 2023 Jun;40(6):431-436. doi: 10.1136/emermed-2022-212872. Epub 2023 Apr 17. Emerg Med J. 2023. PMID: 37068929 Free PMC article.
-
Maintenance therapy with a P2Y12 receptor inhibitor after cangrelor in patients with acute coronary syndrome. The ELECTRA-SIRIO 2 investigators' viewpoint.Cardiol J. 2025;32(1):83-89. doi: 10.5603/cj.98323. Epub 2025 Jan 8. Cardiol J. 2025. PMID: 39776051 Free PMC article. Review.
-
Early treatment with inhibitors of P2Y12 receptor in patients with ST-segment elevation myocardial infarction - 2023 ESC recommendations and scientific evidence. Is clinical evidence sufficient to suggest a move towards precision medicine? The ELECTRA-SIRIO 2 investigators' viewpoint.Cardiol J. 2025;32(2):189-194. doi: 10.5603/cj.99973. Epub 2025 Mar 20. Cardiol J. 2025. PMID: 40109248 Free PMC article. Review.
-
Andexanet alfa - Recommendations for clinical use. Multidisciplinary experts' standpoint.Cardiol J. 2023;30(4):502-505. doi: 10.5603/CJ.a2023.0043. Epub 2023 Jul 4. Cardiol J. 2023. PMID: 37401419 Free PMC article. No abstract available.
References
-
- Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC) Eur Heart J. 2018;39(2):119–177. doi: 10.1093/eurheartj/ehx393. - DOI - PubMed
-
- Valgimigli M, Bueno H, Byrne RA, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS) Eur Heart J. 2018;39(3):213–260. doi: 10.1093/eurheartj/ehx419. - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical